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Abstract Artemisinin is a natural product used as an alterna-
tive drug in the treatment of severe and multidrug-resistant
malaria. In the present work we show that artemisinin shares
with other sesquiterpene lactones the ability to inhibit the acti-
vation of the nuclear factor NF-kB: by this mechanism, arte-
misinin, as well as parthenolide, inhibits nitric oxide synthesis in
cytokine-stimulated human astrocytoma T67 cells. These results
suggest that artemisinin, in addition to its antiparasitic proper-
ties, could also exert a therapeutic e¡ect on neurological com-
plications of malaria.
& 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Every year 100 of million people get ill of malaria and
about one million die because of neurological complications
[1]. As the number of Plasmodium falciparum strains resistant
to chloroquine and other conventional antimalarial drugs is
progressively increased [2], the use of alternative drugs has
deserved a growing interest: for instance, artemisinin, a nat-
ural product discovered by the traditional Chinese medicine,
and its derivatives are deemed to be the most e¡ective and
safe drugs for the treatment of severe and multidrug-resistant
malaria [3]. The exact mechanism of action of this sesquiter-
pene lactone endoperoxide, derived from the leafy portions of
Artemisia annua, is not completely clari¢ed: it has been sug-
gested that its antiparasitic e¡ects involve the generation of an
oxidative stress [4].
Several sesquiterpene lactones are known to impair the ac-
tivity of the transcriptional factor NF-kB [5], by alkylating it
[6,7] or preventing the degradation of its inhibitory protein
IkB [8^10]. NF-kB controls the expression of genes involved
in cytokine production, cellular adhesion, in£ammation and
apoptosis [11]. The inducible nitric oxide synthase (iNOS)
gene is NF-kB-regulated: iNOS catalyzes the generation of
nitric oxide (NO), a molecule playing a role in in£ammation
and immune response [12]. During £ogistic processes, the cy-
tokines interleukin-1 beta (IL-1L), interferon-gamma (IFN-Q),
tumor necrosis factor-alpha (TNF-K) and the bacterial lipo-
polysaccharide (LPS) induce an increase of iNOS level in
macrophages [12]. The circulating levels of TNF-K and IL-
1L correlate with the severity of P. falciparum malaria, and
a high intracerebral level of NO has been proposed to medi-
ate, at least partly, the neurological disorders observed in ce-
rebral malaria [13]. The plasmatic levels of nitrite and nitrate
(stable NO derivatives) are increased in patients with P. falci-
parum and P. vivax malaria, and are related to the severity of
the disease [14], being higher in patients with cerebral malaria
[15]. Some sesquiterpene lactones a¡ect the synthesis of NO
[9,10,16^18], and in some cases they have been demonstrated
to exert this e¡ect via NF-kB inhibition [10].
In our work we have studied the e¡ect of artemisinin and
parthenolide on NO synthesis in a human astrocytoma cell
line (T67), and investigated the mechanism by which artemi-
sinin and parthenolide modulate NO production.
2. Materials and methods
2.1. Reagents
Fetal bovine serum (FBS) and Dulbecco’s minimum essential me-
dium (DMEM) were supplied by Gibco BRL (Paisley, Scotland);
L-[2,3,4,5-3H]arginine monohydrochloride (62 Ci/mmol) was obtained
from Amersham International (Bucks, UK). Electrophoresis reagents
were from Bio-Rad Laboratories (Hercules, CA, USA). The protein
content of cell monolayers and cell lysates was assessed with the BCA
kit from Pierce (Rockford, IL, USA). If not otherwise speci¢ed, other
reagents were purchased from Sigma Chemical Co. (St. Louis, MO,
USA) and Aldrich (Milan, Italy). Parthenolide and artemisinin were
dissolved in DMSO (¢nal solvent concentration less than 0.1% v/v).
2.2. Cells
Human astrocytoma T67 cells [19] were a gift from Prof. Giuliana
Maria Lauro (Department of Biology, University of Rome 3, Rome,
Italy). The N11 mouse glial cell line was a gift from Dr. Marco Righi
(CNR Insitute of Neuroscience, Section of Cellular and Molecular
Pharmacology, Milan, Italy). Cells were cultured up to the con£uence
in 35- or 100-mm diameter Petri dishes with DMEM supplemented
with 10% FBS, then were incubated for 24 h with various reagents, as
described in Section 3.
2.3. Measurement of NOS activity and nitrite production
Cells grown at con£uence on 35-mm diameter Petri dishes, after a
24-h incubation in the experimental conditions described in Section 3,
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were lysed and NOS activity was checked as the ability of the cell
lysates to convert L-[3H]arginine to [3H]citrulline during 15 min, as
previously described [20]. Enzyme activity was expressed as pmol
citrulline/min/mg cell protein. In parallel, the nitrite concentration
in the culture medium was measured with the Griess method, as
previously described [20], and expressed as nmol nitrite/24 h/mg cell
protein.
2.4. Western blot
Whole cell extracts, obtained as previously described [21], contain-
ing equal amounts of proteins (30 Wg) were electrophoresed in a 8%
polyacrylamide gel, transferred to PVDF membrane sheets (Immobi-
lon-P, Millipore) and probed with anti-iNOS (from mouse; diluted
1:500 in PBS^BSA 1%, Transduction Laboratories, Lexington, KY,
USA), anti-L-actin (from rabbit; diluted 1:250 in PBS^BSA 1%, Sig-
ma) or anti-IkB-K (from rabbit, diluted 1:200 in PBS^BSA 1%, Santa
Cruz Biotechnology, DBA, Italy) antibodies; after a 1-h incubation,
the membrane was washed with PBS^Tween 0.1% and subjected for
1 h to a peroxidase-conjugated anti-mouse or anti-rabbit IgG (sheep;
Amersham International, diluted 1:1000 in PBS^Tween with Blocker
Non-Fat Dry Milk 5%, Bio-Rad). The membrane was washed again
with PBS^Tween and proteins were detected by enhanced chemilumi-
nescence (Amersham International).
2.5. Real-time reverse transcriptase-polymerase chain reaction
(RT-PCR)
Total RNA was obtained as previously described [21] and real-time
RT-PCR was carried out using the prepared cDNA as a template, as
described in [22]. The same cDNA preparation was used for the
quanti¢cation of iNOS and L-actin, used as a housekeeping gene.
Human iNOS-speci¢c primers and probes were designed with the
Beacon Designer Premier Biosoft International Software (Palo Alto,
CA, USA) using published cDNA sequences (Accession No. L09210)
and were custom-made by Invitrogen (Milan, Italy). The sequences of
iNOS primers for quantitative RT-PCR are 5P-CAGCGGGATGAC-
TTTCCAAG-3P, 5P-AGGCAAGATTTGGACCTGCA-3P ; cycling:
one cycle at 50‡C for 2 min, one cycle at 95‡C for 10 min followed
by 40 cycles at 95‡C for 15 s and annealing/extension at 60‡C for
1 min. To perform the relative quantitation of each sample, the
iNOS PCR product was compared with the L-actin product and
expressed as Relative Expression using the Bio-Rad Software Gene
Expression Quantitation.
2.6. Electrophoretic mobility shift assay (EMSA) of NF-kB and AP-1
Cells were plated in 100-mm diameter dishes at con£uence and all
procedures for nuclear protein extraction were performed at 4‡C with
ice-cold reagents. Cells were mechanically scraped in PBS and washed,
then 1U107 cells were resuspended in 500 Wl of lysis bu¡er A (15 mM
KCl, 10 mM HEPES, 2 mM MgCl2, 0.1 mM EDTA, 1 mM PMSF,
1 mM dithiothreitol (DTT), 10 Wg/ml aprotinin, 2 Wg/ml leupeptin,
0.1% NP-40, pH 7.6). Cell suspensions were then incubated for 10^
15 min on ice with occasional vortexing, and centrifuged for 30 s to
pellet nuclei, which were rinsed with wash bu¡er B (2 mM KCl,
25 mM HEPES, 0.1 mM EDTA, 1 mM PMSF, 1 mM DTT, 10 Wg/
ml aprotinin, 2 Wg/ml leupeptin, pH 7.6) and incubated at 4‡C for
20 min. Nuclear extracts were then prepared by centrifugation at
20 000Ug for 15 min in bu¡er C (25 mM HEPES, 0.1 mM EDTA,
20% glycerol, pH 7.6) and stored at 380‡ until used for EMSA. The
probes contained the NF-kB or the AP-1 oligonucleotide consensus
sequence and were labeled with Q-32P (Amersham Life Science) (3000
Ci/mmol, 250 WCi) using T4 polynucleotide kinase (Boehringer Mann-
heim). The sequences of oligonucleotides used were (binding sites
underlined): NF-kB [5P-AGTTGAGGGGACTTTCCCAGG-3P]
(Promega); AP-1 [5P-CGTTTGATGAGTCAGCCGGAA-3P] (Prome-
ga). 10 Wg of extracts was incubated for 20 min with 20 000 cpm of
32P-labeled double-stranded oligonucleotide at 4‡C in a 25 Wl reaction
mixture containing: 10 Wg/ml BSA, 10U bu¡er D (100 mM KCl,
20 mM HEPES, 0.5 mM EDTA, 2 mM DTT, 0.1 mM PMSF, 20%
glycerol, 0.25% NP-40, pH 7.6), 5U bu¡er F (300 mM KCl, 100 mM
HEPES, 10 mM DTT, 100 WM PMSF, 20% Ficoll, pH 7.6) and 1 Wg/
Wl poly(dI-dC). In competition assays, 100U cold NF-kB or AP-1
competitor was added. The DNA^protein complex was separated
on a non-denaturating 4% polyacrylamide gel in TBE bu¡er (Tris^
HCl, boric acid, EDTA 2 mM, pH 8.0). After electrophoresis, the gel
was dried and autoradiographed by overnight exposure to X-ray ¢lm.
2.7. Statistical analysis
Each experimental point has been performed in duplicate or tripli-
cate per experiment; all data in the text and ¢gures are given as
meansSS.E.M. Statistical analysis was carried out using the Student’s
t-test for unpaired data.
3. Results and discussion
3.1. Artemisinin and parthenolide inhibit nitrite production and
NOS activity and expression
Micromolar doses of sesquiterpene lactones have already
been shown to inhibit nitrite levels, NOS activity and expres-
sion [10,16]. We investigated the e¡ect of artemisinin and
parthenolide in T67 cells, possessing an iNOS isoform which
is known to be stimulated by the treatment with LPS and
cytokines [23]. Cells were incubated for 24 h with artemisinin
or parthenolide, in the presence or absence of a mix contain-
ing LPS, IL-1L, IFN-Q, and TNF-K : the nitrite level in the
culture medium was not modi¢ed by artemisinin or partheno-
lide alone, while both molecules signi¢cantly reverted the in-
crease of nitrite induced by the LPS/cytokines mix (Fig. 1).
The same e¡ect was observed when NOS activity was mea-
sured in the lysates of cells previously incubated with either
sesquiterpene lactone for 24 h (Fig. 1). Therefore artemisinin,
similarly to parthenolide, was able to inhibit the LPS/cyto-
kine-induced increase of NOS activity, measured as both ni-
trite accumulation in the extracellular medium and ability of
the cell lysate to convert [3H]arginine to [3H]citrulline. The
measurement of NOS in the cell lysate provides information
about the content of catalytically active enzyme: indeed, cit-
rulline production in the lysate is an index of the maximal
NOS activity, i.e. measured in the presence of saturating con-
centrations of substrate and in the absence of the cell regu-
latory control. Put di¡erently, the nitrite accumulation in the
supernatant of cultured cells depends on the actual NO syn-
thesis by whole, viable cells.
Fig. 1. NOS activity (open bars) and nitrite levels (hatched bars) in
T67 cells incubated for 24 h in DMEM+10% FBS in the absence
(ctrl) or presence of a LPS/cytokines-containing mix (mix: 20 Wg/ml
LPS, 50 ng/ml TNF-K, 100 ng/ml IFN-Q, 10 ng/ml IL-1L), 10 WM
parthenolide (part) or 10 WM artemisinin (art), alone or in combina-
tion with the mix. After this time, NOS activity was measured in
the cell lysates and extracellular medium was checked for nitrite
concentration (see Section 2). Measurements were performed in du-
plicate, and data are presented as meansSS.E.M. (n=5); vs. ctrl :
**P6 0.02, *P6 0.05; versus mix: ‡P6 0.002.
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Western blot experiments showed that a 24-h incubation
with the LPS/cytokines mix induced a strong increase of
iNOS protein expression: this e¡ect was completely abrogated
by the co-incubation with both artemisinin and parthenolide
(Fig. 2). In real-time RT-PCR experiments, the mix strongly
induced the iNOS mRNA transcription; this increment was
blunted when LPS-stimulated cells were incubated with arte-
misinin or parthenolide (Fig. 3).
3.2. Artemisinin and parthenolide block the
LPS/cytokine-induced activation of NF-kB
NF-kB is a heterodimeric cytosolic protein, which in resting
cells is kept inactive by the binding with a member of the IkB
inhibitor protein family [24]. After phosphorylation, IkB is
ubiquitinylated and degraded by a proteasome system and
NF-kB can translocate to the nucleus promoting iNOS tran-
scription [25]. Our EMSA experiments, performed in nuclear
extracts, showed that NF-kB was activated by a 24-h stimu-
lation with the LPS/cytokines mix, and translocated into the
nucleus (Fig. 4). Both artemisinin and parthenolide com-
pletely reverted the e¡ect of the mix (Fig. 4). To evaluate
the speci¢ty of the drug’s e¡ects, we investigated the nuclear
translocation of another transcription factor, AP-1, in the
same extracts and at the same experimental conditions: in
this case both artemisinin and parthenolide did not signi¢-
cantly modify the activation of AP-1 (Fig. 4). As LPS/cyto-
kine-elicited NF-kB activation is mediated by the phosphory-
lation and subsequent proteolytic degradation of the
inhibitory protein IkB [26], we investigated whether artemisi-
nin and parthenolide could interfere with this step. Western
blot analysis showed that the level of IkBK was signi¢cantly
reduced in LPS/cytokine-treated cells, and both artemisinin
and parthenolide restored IkBK expression when incubated
together with the LPS/cytokines mix (Fig. 5). These results
suggest that artemisinin, as well as parthenolide, prevents
the LPS-induced proteolytic degradation of IkBK protein
and the consequent activation and translocation of NF-kB,
thus accounting for the suppression of iNOS gene expression
and NO synthesis in cells stimulated with LPS/cytokines. Par-
thenolide (10 WM for 1 h) has already been shown to inhibit
activation of NF-kB in Jurkat T leukemia cells [8], and NF-
kB translocation and iNOS transcription in LPS/IFN-Q-stimu-
lated rat aortic smooth muscle cells [9] ; in both cases the drug
prevented the degradation of IkB [8,9]. On the other hand, in
Fig. 2. Western blot detection of iNOS in T67 cells, incubated for
24 h in the absence (ctrl) or presence of the LPS/cytokines mix
(mix: see legend of Fig. 1), 10 WM parthenolide (part) or 10 WM ar-
temisinin (art), alone or in combination with the LPS/cytokines mix.
The experiment in the upper panel is representative of three similar
experiments. Western blot has also been performed in the same cell
lysates with antibodies against the housekeeping protein L-actin, as
a control of the gel protein loading. The protein bands have been
quantitated densitometrically; the values, expressed as arbitrary
units, are represented in the lower panel as meansSS.E.M. (n=3);
vs. control: *P6 0.05; versus mix: ‡P6 0.05.
Fig. 3. Real-time RT-PCR of iNOS mRNA in T67 cells incubated
in the absence (ctrl) or presence of the LPS/cytokines mix (mix: see
legend of Fig. 1), 10 WM parthenolide (part) or 10 WM artemisinin
(art), alone or in combination with the LPS/cytokines mix (n=3).
The RT-PCR e⁄ciency was controlled by amplifying a L-actin frag-
ment, used as a housekeeping gene. The iNOS PCR product was
compared with the L-actin product and expressed as relative expres-
sion versus L-actin, in terms of percentage of control (assumed as
100%). Vs. ctrl : *P6 0.01; vs. mix: ‡P6 0.02.
Fig. 4. EMSA detection of NF-kB (upper panel) and AP-1 (lower
panel) activation. Cells were incubated for 24 h in the absence (ctrl)
or presence of the LPS/cytokines mix (mix: see legend of Fig. 1), 10
WM parthenolide (part) or 10 WM artemisinin (art), alone or in com-
bination with the LPS/cytokines mix. Nuclear extracts were sub-
jected to EMSA as described in Section 2; in the last lane of each
experiment the sample incubated with LPS/cytokines was mixed not
only with the labeled oligonucleotide probe but also with 100U
cold oligonucleotide as speci¢c competitor (cold oligo). These ex-
periments are representative of three similar experiments per each
transcription factor.
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primary cultures of rat microglial cells parthenolide inhibited
the LPS-elicited NO synthesis and iNOS induction, but it did
not prevent the LPS-induced activation of NF-kB and IkBK
degradation [18]. The di¡erences in experimental conditions
and glial cell strains could account for this discrepancy, but
we cannot exclude other mechanisms of action. Anyway, the
e¡ects we have observed in this work are not speci¢c of T67
human astrocytoma cells : indeed, we were able to reproduce
the same experimental results also in the N11 mouse glial cell
line, using LPS as an iNOS inducer (data not shown).
Cerebral malaria has been attributed to vessel occlusion by
infected erythrocytes [27] and/or to excessive TNF-K levels,
generated by endothelial cells and stimulated macrophages
[28]. TNF-K can induce NO overproduction in the central
nervous system, which has been related to neuronal dysfunc-
tion in several diseases, including malaria [13]. Our data sug-
gest a new mechanism of action for artemisinin: its well-
known positive e¡ect on severe malaria could be accounted
for not only by its ability to reduce the parasite burden, but
also by its capacity to suppress NF-kB-mediated NO synthe-
sis. Furthermore, owing to this property, artemisinin could be
studied for its potential role as an anti-in£ammatory agent,
like parthenolide and other sesquiterpene lactones.
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Fig. 5. Western blot detection of IkBK. After a 24-h incubation in
the absence (ctrl) or presence of the LPS/cytokines mix (mix: see
legend of Fig. 1), 10 WM parthenolide (part) or 10 WM artemisinin
(art), alone or in combination with the LPS/cytokines mix, cellular
extracts were analyzed by Western blot with an anti-IkB-K antibody
(see Section 2 for details). The experiment in the upper panel is rep-
resentative of three similar experiments. The protein bands have
been quantitated densitometrically; the values, expressed as arbi-
trary units, are represented in the lower panel as meansSS.E.M.
(n=3); vs. control: *P6 0.05.
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